BioInvent International AB logo

BioInvent International AB

BioInvent is translating cancer antibody biology into innovative immuno-oncology therapies.

139 employees · est. 1983 · Lund, Sweden

VS
Bright Biologics logo

Bright Biologics

Developing bispecific antibody drug to improve cancer treatment.

6 employees · est. 2020 · Sunnyvale, United States

BioInvent International AB is the older company (1983 vs 2020); BioInvent International AB is the larger of the two.

Side-by-Side Comparison

BioInvent International AB Bright Biologics
Founded
1983 older 2020
Headquarters
Lund, Sweden Sunnyvale, United States
Employees
139 larger 6
Industry
Biotechnology, Health Care, Manufacturing Biotechnology, Health Care, Health and Wellness
Funding Stage
IPO Not tracked yet
Total Funding
$5.64M Not tracked yet
Funding Rounds
6 Not tracked yet
Services
Antibody Discovery and Development, Clinical Programs in Immuno-oncology, Contract Manufacturing for Clinical Trials, Collaboration with Pharmaceutical Companies Not tracked yet
Target Customers
Cancer Patients, Biotech and Pharmaceutical Companies, Medical Professionals, Clinical Researchers Not tracked yet
Taxonomy
Immuno-Oncology, Antibody Drug Development, Hematological Cancer Therapy, Solid Tumor Therapy, F.I.R.S.T™ Technology Platform, N-CoDeR™ Antibody Library, Clinical-Stage Biotech, Research Collaborations, License Agreements, Antibody Manufacturing, Process Development, Antibody Drug Discovery, Co-Development Agreements, Proprietary Antibody Selection Bispecific Antibody Drug, Therapeutic Antibodies, Cancer Treatment, VHH Antibody Discovery, Antibody Drug Development, Molecular Biology, Protein Chemistry, ADC, Cancer Research
Website
bioinvent.com brightbiologicsllc.com
BioInvent International AB logo

About BioInvent International AB

BioInvent International AB, a clinical-stage biotech firm founded in 1983 and headquartered in Sweden, is pioneering the landscape of immuno-oncology therapies by translating cancer antibody biology into innovative treatments. Leveraging its unique F.I.R.S.T™ technology platform, the company is at t...

Bright Biologics logo

About Bright Biologics

Bright Biologics is a United States-based startup that focuses on developing bispecific antibody drugs to improve cancer treatment. They aim to target clinically proven targets and utilize a highly efficient VHH antibody discovery platform and state-of-the-art screening technology for drug developme...

We will tell you when either one moves

BounceWatch watches BioInvent International AB and Bright Biologics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BioInvent Internationa... and Bright Biologics — by email.

Frequently Asked Questions

BioInvent International AB — BioInvent is translating cancer antibody biology into innovative immuno-oncology therapies.. Bright Biologics — Developing bispecific antibody drug to improve cancer treatment.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BioInvent International AB has raised $5.64M while Bright Biologics has raised undisclosed funding.
BioInvent International AB and Bright Biologics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BioInvent International AB with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BioInvent International AB on 15 Jun 2026, and Bright Biologics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy